Latest Plasmodium falciparum Stories
Biologists at the University of California, San Diego have succeeded in engineering algae to produce potential candidates for a vaccine that would prevent transmission of the parasite that causes malaria, an achievement that could pave the way for the development of an inexpensive way to protect billions of people from one of the world's most prevalent and debilitating diseases.
Biologists at the University of California, San Diego have revealed their progress in engineering algae for a vaccine that could possibly counter transmission of the parasite that causes malaria.
Last year it killed an estimated 655,000 people. Now researchers are developing new ways to block the transmission of Plasmodium, the parasite responsible for human malaria.
Over 200 million people contract malaria each year, and according to the World Health Organization, an estimated 655,000 people died from malaria in 2010.
Scientists have expressed concerns that resistance to the primary treatment for malaria is increasing, potentially putting thousands of additional people at risk of losing their lives to the disease.
Evidence that the most deadly species of malaria parasite, Plasmodium falciparum, is becoming resistant to the front line treatment for malaria on the border of Thailand and Myanmar (Burma) is reported in The Lancet today.
Emergence of resistance to the drug artemisinin in western Thailand has created a critical point in global efforts to control and eliminate malaria worldwide.
Scientists from the University of Liverpool are working with computer modeling specialists in India to predict areas of the country that are at most risk of malaria outbreaks, following changes in monsoon rainfall.
Malaria infections among infants can be cut by up to 30 per cent when antimalarial drugs are given intermittently over a 12 month period, a three-year clinical trial in Papua New Guinea has shown.
Tourists who have visited a malaria-infected country and are over the age of 65 are almost 10 times more likely to die from the disease than those who are aged 18-35.